Middle East & Africa Clinic Casting and Splinting Products Market
Middle East & Africa Clinic Casting and Splinting Products Market is growing at a CAGR of 3.3% to reach US$ 54.64 million by 2030 from US$ 42.19 million in 2022 by Product and Splinting, Application and Material.

Published On: Nov 2023

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Clinic Casting and Splinting Products Market

At 3.3% CAGR, the Middle East & Africa Clinic Casting and Splinting Products Market is projected to be worth US$ 54.64 million by 2030, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa clinic casting and splinting products market was valued at US$ 42.19 million in 2022 and is expected to reach US$ 54.64 million by 2030, registering a CAGR of 3.3% from 2022 to 2030. Rising prevalence of musculoskeletal conditions and high prevalence of age-related orthopedic disorders are the critical factors attributed to the Middle East & Africa clinic casting and splinting products market expansion.

According to the World Health Organization (WHO) musculoskeletal conditions are the leading cause of disability across the world, and low back pain is the single leading cause of disability in 160 countries. Musculoskeletal disorders ranked first in years lived with disability (YLDs) and sixth in disability-adjusted life-years (DALYs) globally in 2019. According to WHO, ∼1.71 billion people across the world had musculoskeletal conditions in 2021.

Rheumatoid arthritis (RA), osteoarthritis (OA), low-back pain (LBP), and neck pain (NP) are a few common musculoskeletal conditions. According to an article published by Springer Nature in 2023, rheumatoid arthritis, one of the main autoimmune rheumatic diseases, affects 14 million people worldwide. Joint pain is the most common reason for specialist referrals. Cast or splint is used in the management of various musculoskeletal conditions. To maximize benefits while minimizing complications, the use of casts and splints is generally limited to the short term. Thus, the rising incidence of musculoskeletal conditions is driving the growth of the Middle East & Africa clinic casting and splinting products market.

On the contrary, complications related to casting and splinting hamper the Middle East & Africa clinic casting and splinting products market.  

Based on product, the Middle East & Africa clinic casting and splinting products market is segmented into casting and splinting. The casting segment held 64.7% share of Middle East & Africa clinic casting and splinting products market in 2022, amassing US$ 27.29 million. It is projected to garner US$ 34.60 million by 2030 to expand at 3.0% CAGR during 2022–2030. The casting is sub-segmented into casts, tapes, cutters, and casting accessories. The splinting segment is further segmented into splints and splinting accessories.

Based on application, the Middle East & Africa clinic casting and splinting products market is segmented into acute fractures or sprains, tendon and ligament injuries, and others. The acute fractures segment held 49.9% share of Middle East & Africa clinic casting and splinting products market in 2022, amassing US$ 21.05 million. It is projected to garner US$ 27.87 million by 2030 to expand at 3.6% CAGR during 2022–2030.

Based on material, the Middle East & Africa clinic casting and splinting products market is segmented into Plaster of Paris, fiberglass, and others. The Plaster of Paris segment held 48.5% share of Middle East & Africa clinic casting and splinting products market in 2022, amassing US$ 20.47 million. It is projected to garner US$ 26.08 million by 2030 to expand at 3.1% CAGR during 2022–2030.

Based on country, the Middle East & Africa clinic casting and splinting products market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 38.3% share of Middle East & Africa clinic casting and splinting products market in 2022. It was assessed at US$ 16.15 million in 2022 and is likely to hit US$ 21.79 million by 2030, exhibiting a CAGR of 3.8% during 2022–2030.      

Key players operating in the Middle East & Africa clinic casting and splinting products market are 3M Co, DeRoyal Industries Inc, Enovis Corp, Essity AB, Ossur hf, Prime Medical Inc, and Zimmer Biomet Holdings Inc, among others. 

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com